R
Reinhild Prinz-Langenohl
Researcher at University of Bonn
Publications - 14
Citations - 1123
Reinhild Prinz-Langenohl is an academic researcher from University of Bonn. The author has contributed to research in topics: Vitamin & Body mass index. The author has an hindex of 13, co-authored 13 publications receiving 1061 citations.
Papers
More filters
Journal ArticleDOI
Potential determinants of obesity among children and adolescents in Germany: Results from the cross-sectional KiGGS study
Christina Kleiser,Angelika Schaffrath Rosario,Gert B. M. Mensink,Reinhild Prinz-Langenohl,Bärbel-Maria Kurth +4 more
TL;DR: The strongest association with obesity was observed for parental overweight and for low SES, and long sleep time was negatively associated with obesity among 3- to 10-year olds.
Journal ArticleDOI
Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age
TL;DR: It is shown that administration of [6S]-5-MTHF is more effective than is folic acid supplementation at improving folate status, and the recommended period for preconceptional folic Acid supplementation should be extended to >4 wk for maximal prevention of NTDs.
Journal ArticleDOI
5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.
Iris P Fohr,Reinhild Prinz-Langenohl,Anja Brönstrup,Anja M Bohlmann,Heinz Nau,Heiner K. Berthold,Klaus Pietrzik +6 more
TL;DR: In women with the CT or CC genotype, FA is more effective than MTHF in lowering plasma tHcy, and Women with the TT genotype seem to benefit the most from supplementation with either FA or MTHf.
Journal ArticleDOI
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
TL;DR: The addition of vitamin B-12 to folic acid supplements or enriched foods maximizes the reduction of homocysteine and may increase the benefits of the proposed measures in the prevention of vascular disease and neural tube defects.
Journal ArticleDOI
Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women
TL;DR: 6S]-5-MTHF was shown to be an adequate alternative to folic acid in reducing tHcy concentrations and was no more effective than that with 208 micro g [6S]5- MTHF.